KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) FCF Payout Ratio (2019 - 2025)

Historic FCF Payout Ratio for Royalty Pharma (RPRX) over the last 7 years, with Q3 2025 value amounting to 0.13.

  • Royalty Pharma's FCF Payout Ratio fell 10929.12% to 0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17, marking a year-over-year increase of 13008.91%. This contributed to the annual value of 0.48 for FY2024, which is 24689.69% up from last year.
  • Latest data reveals that Royalty Pharma reported FCF Payout Ratio of 0.13 as of Q3 2025, which was down 10929.12% from 0.11 recorded in Q2 2025.
  • In the past 5 years, Royalty Pharma's FCF Payout Ratio registered a high of 5.46 during Q1 2021, and its lowest value of 0.72 during Q4 2021.
  • Over the past 5 years, Royalty Pharma's median FCF Payout Ratio value was 0.08 (recorded in 2022), while the average stood at 0.27.
  • As far as peak fluctuations go, Royalty Pharma's FCF Payout Ratio soared by 115768.27% in 2021, and later crashed by 88120.14% in 2024.
  • Royalty Pharma's FCF Payout Ratio (Quarter) stood at 0.72 in 2021, then soared by 114.34% to 0.1 in 2022, then tumbled by 202.85% to 0.11 in 2023, then soared by 219.81% to 0.13 in 2024, then plummeted by 203.48% to 0.13 in 2025.
  • Its last three reported values are 0.13 in Q3 2025, 0.11 for Q2 2025, and 0.09 during Q1 2025.